Protocol summary

Study aim
effects of Slimtak (Combination of green tea dry extract and Cichorium intybus roots Extract) compared to placebo on weight loss in obese or overweight adults
Design
Clinical trial with placebo control group, with parallel groups, double blinded, randomized, on 80 individuals with overweight/obesity, randomization with blocks of size 4 using software
Settings and conduct
The place of the study: private clinic in Tehran; Population: people with overweight and obesity; type of blinding: double blinded; blinding, randomization and preparation of supplement cans will be done by a trained person outside the study until participants, researchers and analyzer remain blind until the end of the analysis. At the beginning and end of the intervention with supplement or placebo weight, height, BMI, and body composition will be measured. Participants in both groups will receive weight loss diets based intervention with supplement/placebo during the study period. Study duration will be 8 weeks.
Participants/Inclusion and exclusion criteria
Inclusion criteria: BMI:25-40, age: 18-65 years, and willing to participate in the study. Exclusion criteria: Using weight reduction medication, substance overuse, pregnancy or lactation, having known kidney disease, and having known heart disease
Intervention groups
Supplement group: 3 Slimtak capsule with each meal and weight reduction diet, Placebo group: 2 placebo capsules with each meal and weight reduction diet for 8 weeks
Main outcome variables
weight; fat mass; fat free mass; BMI

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20140804018677N25
Registration date: 2023-03-29, 1402/01/09
Registration timing: prospective

Last update: 2023-03-29, 1402/01/09
Update count: 0
Registration date
2023-03-29, 1402/01/09
Registrant information
Name
soodeh razeghi Jahromi
Name of organization / entity
Tehran University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 21 6634 8500
Email address
razeghi@sina.tums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-04-03, 1402/01/14
Expected recruitment end date
2023-09-05, 1402/06/14
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effects of Slimtak (Combination of green tea dry extract and Cichorium intybus roots Extract) compared to placebo on weight loss in obese or overweight adults
Public title
Effects of Slimtak (Combination of green tea dry extract and Cichorium intybus roots Extract) on weight loss in obese or overweight adults
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Body mass index of 25-40 age of 16-65years Willing to participate
Exclusion criteria:
Consuming weight reduction medications substance overuse Pregnancy and lactation Having known kidney disease Having known heart disease
Age
From 18 years old to 65 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 80
Randomization (investigator's opinion)
Randomized
Randomization description
Participants in the study are selected by convenience sampling method. Patients are classified according to age and gender, and each person will be placed in a group receiving supplementation or placebo using 1:1, quadruple random blocks. Quadruple blocks are randomly designed through software such as ...... (ABAB), (BBAB), (AABB), (ABBA), (BAAB). Assigning A or B to the supplement or placebo group will be done by someone outside the research so that the researchers remain blind. According to the list of randomly prepared quadruple blocks, a trained person outside the research team is responsible for randomly assigning patients. After each patient enters, according to the quadruple blocks prepared in the first stage, each patient is randomly assigned to group A or B. Assignment process will be done consecutively until the sampling is completed.
Blinding (investigator's opinion)
Double blinded
Blinding description
It is a double blind study. Participants, research team including principle investigator, data collectors, and outcome assessors will be blind to supplement or placebo allocation. Blinding would be performed by a third person out of study team. Allocation data would be unavailable to study team till the end of data collection and analysis.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Research Ethics committees of National Nutrition & Food Technology Research Institute
Street address
No. 7, West Arghavan Ave., Farahzadi Blvd., Qods Town
City
Tehran
Province
Tehran
Postal code
1981619573
Approval date
2023-01-22, 1401/11/02
Ethics committee reference number
IR.SBMU.NNFTRI.REC.1401.069

Health conditions studied

1

Description of health condition studied
Overweight and Obesity
ICD-10 code
E66
ICD-10 code description
Overweight and obesity

Primary outcomes

1

Description
Weight
Timepoint
Baseline and after 2 months from the beginning of the study
Method of measurement
Scale

2

Description
Fat mass
Timepoint
Baseline and after 2 months from the beginning of the study
Method of measurement
Omron BF511 body composition scale

3

Description
Fat free mass
Timepoint
Baseline and after 2 months from the beginning of the study
Method of measurement
Omron BF511 body composition scale

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: The duration of intervention in this clinical trial will be 8 weeks. Beside calorie restricted diet (300-500 Kcal less than calculated daily energy need) people will receive 3 capsules of Slimtack (each capsules contains 200 mg green tea dry extract and 80 mg Cichorium intybus roots Extract) (Takin Pars pharmed company) with each meal.
Category
Treatment - Other

2

Description
Control group: The duration of intervention in this clinical trial will be 8 weeks. Beside calorie restricted diet (300-500 Kcal less than calculated daily energy need) people will receive 3 capsoules of placebo (each capsouls contains 500 mg corn starch) (Takin Pars pharmed company) with each meal.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
private clinic
Full name of responsible person
Soodeh Razeghi Jahromi
Street address
No. 7, West Arghavan St., Farahzadi Blv., Qods Town
City
Tehran
Province
Tehran
Postal code
1981619573
Phone
+98 21 2235 7483
Email
soodehrazeghi@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Takin Pars pharmed Company
Full name of responsible person
ساحل رحیمی
Street address
Zagros Building, No. 37, 1st East Boostan, Farahzadi Boulevard, Shahrak-e Qods, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
191574323
Phone
+98 21 4300 0070
Email
soodehrazeghi@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Takin Pars pharmed Company
Proportion provided by this source
100
Public or private sector
Private
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Industry

Person responsible for general inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Soodeh Razghei Jahromi
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
No. 7, West Arghavan St., Farahzadi Blv., Qods Town
City
Tehran
Province
Tehran
Postal code
4741-19395
Phone
+98 21 2235 7483
Email
soodehrazeghi@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Soodeh Razghei Jahromi
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
No. 7, West Arghavan St., Farahzadi Blv., Qods Town
City
Tehran
Province
Tehran
Postal code
4741-19395
Phone
+98 21 2235 7483
Email
soodehrazeghi@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Soodeh Razghei Jahromi
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
No. 7, West Arghavan St., Farahzadi Blv., Qods Town
City
Tehran
Province
Tehran
Postal code
4741-19395
Phone
+98 21 2235 7483
Email
soodehrazeghi@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
Coded data of the participants, study protocol, and report of the main output of the study would be available in case of researchers' reasonable request sending to principal investigator of the study 6 months after publishing the article.
When the data will become available and for how long
starting 6 months after publication
To whom data/document is available
University researchers
Under which criteria data/document could be used
Have no other condition
From where data/document is obtainable
Email to soodehrazeghi@gmail.com
What processes are involved for a request to access data/document
sending email
Comments
Loading...